FDA airs antibody test performance specs, educational video

By LabPulse.com staff writers

June 5, 2020 -- The U.S. Food and Drug Administration (FDA) has published detailed performance specifications for four more commercial antibody tests. Separately, the agency has published an educational video about serology and other types of COVID-19 assays.

Many tests for immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies have been introduced, some of which have received emergency use authorization (EUA) from the FDA. Recently, the FDA has tightened its policies and published a list of products that have been removed from eligibility to market.

The FDA has also been assessing tests in conjunction with other U.S. government agencies. As part of this cross-government process, to date the agency has published performance data -- sensitivity, specificity, positive and negative predictive value -- for the following products, noting market status:

  • Euroimmun's SARS-CoV-2 ELISA (IgG): EUA authorized
  • Healgen's IgG/IgM rapid test cassette: EUA authorized
  • Tianjin Beroni Biotechnology's IgG/IgM antibody detection kit: Should not be distributed, removed
  • Phamatech's COVID-19 rapid test: Should not be distributed, voluntarily withdrawn
  • BioMedomics' COVID-19 IgM/IgG rapid test kit: Should not be distributed, voluntarily withdrawn

As of June 3, the agency had granted 120 EUAs -- for 104 molecular tests, 15 antibody tests, and one antigen test. The agency also has published an educational video explaining tests for COVID-19, including molecular, IgG/IgM, and antigen tests.

FDA offers guidance for labs on substituting supplies during pandemic
The U.S. Food and Drug Administration (FDA) has created an online guide for labs on substituting supplies needed for reverse transcription polymerase...
FDA pulls plug on wayward coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) has published the names of 28 coronavirus antibody tests that may no longer be marketed or distributed, as...
AACC provides a steer on antibody testing for novel coronavirus
The American Association for Clinical Chemistry (AACC) is advising that antibody testing for the novel coronavirus should be limited to diagnostics that...
FDA-authorized antibody tests fall short in comparative study
Commercial serology tests from PerkinElmer subsidiary Euroimmun and Abbott fell short of expectations in a comparative study of specimens, underscoring...
FDA policy change may put an end to 'Wild West' of coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) is cracking down on requirements for commercial manufacturers of antibody tests for the novel coronavirus,...

Copyright © 2020 LabPulse.com

Last Updated eh 6/5/2020 9:19:59 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current